Herr Investment Group’s Novavax NVAX Stock Holding History

Herr Investment Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,000	Closed	-$2.06M	–	82
2022 Q4	$2.06M	Buy	+200,000	New	+$3.53M	0.13%	54

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Herr Investment Group's NVAX Position: Q2 2024 in Review

Herr Investment Group sold out of Novavax (NVAX) in Q2 2024, closing a stake of 10,000 shares — an estimated $47.8K sold.

Herr Investment Group first reported a position in NVAX in Q4 2022 and held it in 2 quarters. The position peaked at $14.4M in Q4 2022. 230 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

Herr Investment Group reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
Herr Investment Group sold 10,000 Novavax shares in Q2 2024, an estimated $47.8K.
Herr Investment Group first reported a position in Novavax in Q4 2022 and held it in 2 quarters.
Herr Investment Group's Novavax position peaked at $14.4M in Q4 2022.
230 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Herr Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.